Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:15203153rdf:typepubmed:Citationlld:pubmed
pubmed-article:15203153lifeskim:mentionsumls-concept:C0034830lld:lifeskim
pubmed-article:15203153lifeskim:mentionsumls-concept:C0014898lld:lifeskim
pubmed-article:15203153lifeskim:mentionsumls-concept:C0441655lld:lifeskim
pubmed-article:15203153lifeskim:mentionsumls-concept:C0220781lld:lifeskim
pubmed-article:15203153lifeskim:mentionsumls-concept:C1883254lld:lifeskim
pubmed-article:15203153lifeskim:mentionsumls-concept:C0392747lld:lifeskim
pubmed-article:15203153lifeskim:mentionsumls-concept:C0243076lld:lifeskim
pubmed-article:15203153lifeskim:mentionsumls-concept:C0678594lld:lifeskim
pubmed-article:15203153lifeskim:mentionsumls-concept:C2603343lld:lifeskim
pubmed-article:15203153lifeskim:mentionsumls-concept:C0243071lld:lifeskim
pubmed-article:15203153lifeskim:mentionsumls-concept:C1260969lld:lifeskim
pubmed-article:15203153lifeskim:mentionsumls-concept:C1554963lld:lifeskim
pubmed-article:15203153lifeskim:mentionsumls-concept:C0066393lld:lifeskim
pubmed-article:15203153pubmed:issue14lld:pubmed
pubmed-article:15203153pubmed:dateCreated2004-6-18lld:pubmed
pubmed-article:15203153pubmed:abstractTextThe development of novel agents for the differentiation of neuronal nicotinic acetylcholine receptors (nAChRs) is important for the treatment of a variety of pathological conditions. We have prepared and evaluated a number of simpler analogues of the norditerpeniod alkaloid methyllycaconitine (MLA) in an effort to understand molecular determinants of nAChR*small molecule interactions. We have previously reported the synthesis and evaluation of a series of ring E analogues of MLA. We report here the optimization of the alpha3beta4* functional activity of this series of compounds through modification of the ester.lld:pubmed
pubmed-article:15203153pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15203153pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15203153pubmed:languageenglld:pubmed
pubmed-article:15203153pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15203153pubmed:citationSubsetIMlld:pubmed
pubmed-article:15203153pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15203153pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15203153pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15203153pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15203153pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15203153pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15203153pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15203153pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15203153pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15203153pubmed:statusMEDLINElld:pubmed
pubmed-article:15203153pubmed:monthJullld:pubmed
pubmed-article:15203153pubmed:issn0960-894Xlld:pubmed
pubmed-article:15203153pubmed:authorpubmed-author:BryantDarrell...lld:pubmed
pubmed-article:15203153pubmed:authorpubmed-author:McKayDennis...lld:pubmed
pubmed-article:15203153pubmed:authorpubmed-author:IsmailKhadiga...lld:pubmed
pubmed-article:15203153pubmed:authorpubmed-author:BergmeierStep...lld:pubmed
pubmed-article:15203153pubmed:authorpubmed-author:McKaySusanSlld:pubmed
pubmed-article:15203153pubmed:authorpubmed-author:ArasonKristja...lld:pubmed
pubmed-article:15203153pubmed:issnTypePrintlld:pubmed
pubmed-article:15203153pubmed:day16lld:pubmed
pubmed-article:15203153pubmed:volume14lld:pubmed
pubmed-article:15203153pubmed:ownerNLMlld:pubmed
pubmed-article:15203153pubmed:authorsCompleteYlld:pubmed
pubmed-article:15203153pubmed:pagination3739-42lld:pubmed
pubmed-article:15203153pubmed:dateRevised2007-11-14lld:pubmed
pubmed-article:15203153pubmed:meshHeadingpubmed-meshheading:15203153...lld:pubmed
pubmed-article:15203153pubmed:meshHeadingpubmed-meshheading:15203153...lld:pubmed
pubmed-article:15203153pubmed:meshHeadingpubmed-meshheading:15203153...lld:pubmed
pubmed-article:15203153pubmed:meshHeadingpubmed-meshheading:15203153...lld:pubmed
pubmed-article:15203153pubmed:meshHeadingpubmed-meshheading:15203153...lld:pubmed
pubmed-article:15203153pubmed:meshHeadingpubmed-meshheading:15203153...lld:pubmed
pubmed-article:15203153pubmed:meshHeadingpubmed-meshheading:15203153...lld:pubmed
pubmed-article:15203153pubmed:meshHeadingpubmed-meshheading:15203153...lld:pubmed
pubmed-article:15203153pubmed:meshHeadingpubmed-meshheading:15203153...lld:pubmed
pubmed-article:15203153pubmed:meshHeadingpubmed-meshheading:15203153...lld:pubmed
pubmed-article:15203153pubmed:meshHeadingpubmed-meshheading:15203153...lld:pubmed
pubmed-article:15203153pubmed:year2004lld:pubmed
pubmed-article:15203153pubmed:articleTitleStructure activity studies of ring E analogues of methyllycaconitine. Part 2: Synthesis of antagonists to the alpha3beta4* nicotinic acetylcholine receptors through modifications to the ester.lld:pubmed
pubmed-article:15203153pubmed:affiliationDepartment of Chemistry and Biochemistry, Ohio University, Athens, OH 45701, USA. bergmeis@ohio.edulld:pubmed
pubmed-article:15203153pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:15203153pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:15203153pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...http://linkedlifedata.com/r...pubmed-article:15203153lld:chembl
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15203153lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15203153lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15203153lld:pubmed